1269601

GSK LLC (GlaxoSmithKline) — FEI 3006810568

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 21, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Collegeville, PA (United States)

Additional Details

Sponsor, Contract Research Organization